EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma

BACKGROUND: It is urgent to explore an effective potential therapeutic strategy for ESCC. In recent years, cell-based cancer immunotherapy has become a potentially close for carcinoma therapy. Chimeric antigen receptor (CAR) T cell technology is a kind of adoptive cell therapy technique which has be...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Dis
Hlavní autoři: Shi, Hui, Yu, Feng, Mao, Yinting, Ju, Qianqian, Wu, Yingcheng, Bai, Wen, Wang, Peiwen, Xu, Ran, Jiang, Maorong, Shi, Jiahai
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006048/
https://ncbi.nlm.nih.gov/pubmed/29997940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.04.91
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky